FXI February 2027 Options Begin Trading

iShares China Large-Cap ETF (FXI) is trading at $39.11; a $35 put is bidding $1.87 (sell-to-open obligates purchase at $35 with a net cost basis of $33.13 — ~11% below spot) and is modeled to have a 73% chance of expiring worthless, implying a 5.34% return on cash (5.23% annualized). Conversely, a $45 call bid at $2.14 as a covered-call against a $39.11 position represents a ~15% upside strike and a 20.53% total return if called at Feb 2027, with a 62% chance of expiring worthless and a 5.47% YieldBoost (5.35% annualized). Implied volatilities are ~36% for the put and 34% for the call versus a 12-month realized volatility of 25%.

Analysis

Market structure: The current FXI option landscape benefits option sellers and yield-seeking allocators — selling the Feb 2027 $35 put (collect $1.87 → effective basis $33.13) or a covered-call at $45 (collect $2.14 → 20.5% capped upside) converts equity exposure into carry. It weakly pressures directional buyers because systematic put-writing provides downside support around strikes (~$35) but also caps large upside beyond covered-call strikes, compressing realized upside for long-only holders over the next ~12 months.

Risk assessment: Near-term (days→weeks) the primary risk is IV re-rating and short squeezes; realized vol (25%) is well below implied (34–36%), favoring sellers unless a China-specific shock occurs. Tail risks (months→years) include regulatory action from Beijing, US-China listing/delimitation moves, or sudden CNY depreciation — any of which could push FXI >20–30% lower and force assignment or large mark-to-market losses.

Trade implications: Option-selling is the highest-expected-return play here given IV>realized vol: structured short-put or covered-call allocations sized to absorb assignment are preferred over naked short stock. Cross-asset signals: a China equity bounce would likely tighten yuan, lift commodities (copper, iron ore) and EM beta, while failure would drive USD strength and EM sovereign underperformance.

Contrarian angle: The market underestimates gap risk: 73%/62% “odds” of expiry worthless imply non-negligible ~27–38% chance of downside/upside; sellers are being paid only ~5.3% annualized — inadequate compensation for skew/tail. Historical parallels (2015–2016 China shocks) show option-sellers can be wiped out by regime shifts; prefer structured, size-limited exposures and hedges rather than large naked put books.

Key Decisions for Investors

• Establish a limited sell-to-open position: allocate 2–4% of equity AUM to selling FXI Feb 2027 $35 puts at ~$1.87 (effective basis $33.13). Size to ensure you can hold assigned shares; buy-to-close if FXI < $30 or IV > 45% to limit tail loss.
• If bullish but want income, buy FXI (ticker FXI) sized 2–3% and sell Feb 2027 $45 covered calls for ~$2.14 to realize a capped ~20.5% gross return; roll up/forward if FXI rallies above $42 within 3 months to avoid early assignment.
• Execute a relative-value pair: go long FXI (3% AUM) and short EEM (3% AUM) to express China-specific upside versus broad EM exposure; rebalance monthly and tighten if China PMI or CNY moves ±2% intra-month.
• Use options to hedge tail risk: buy one-year FXI $30 puts (or a put spread $30/$25) allocating 0.5–1% of AUM as insurance if policy/regulatory catalysts emerge over the next 6–12 months.
• Avoid naked large-duration short-put books; only sell puts when IV/realized volatility spread ≥8ppt and maintain stop-loss rules: buy back if IV rises > +10ppt or FXI gaps below strike by >5% intraday.